Sign in
Taking people in United StatesNo phase

Tracking how daily life and surroundings affect blood sugar in type 2 diabetes

Studies blood sugar in adults with type 2 diabetes using wearable and environmental data.

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the 2 sites
Trial code
Registry title
Enhancing Diabetes Care: Exposome &Amp; Sensors
Status
Recruiting
People taking part
20 people, planned
Started
25 Mar 2025
Planned end
31 Jan 2026
Type of study
Observational
Treatments tested
  • Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences
Record updated
25 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 with type 2 diabetes who live in certain listed zip codes. They must be willing to wear a CGM and a sports wristband.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
Diagnosed with type 2 diabetes.

Main reasons for not taking part

  • Any concern that the person does not understand informed consent
  • Unable or unwilling to follow the research protocol

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • People with diabetes in the 18-65 years of age range
  • Diagnosed with type 2 diabetes
  • Resides in the specified high social vulnerability zip codes - 60619, 60620, 60621, 60636, 60644, 60624, 60609, 60612, 60617, 60623, 60628, 60629, 60639, 60645, 60649, 60651, 60652, 60653
  • Speak and understand the English language
  • Willing to wear various devices (CGM and sports wristband)
  • Own a smartphone Exclusion Criteria
  • Subjects will be excluded from the study for the following reasons:
  • Any concern of not understanding informed consent
  • Unable to understand or unwilling to follow research protocol

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of Illinois ChicagoChicago, United StatesContact: Laurie Quinn, PhD RNTaking people
  • University of Illinois College of NursingChicago, United StatesContact: Laurie Quinn Clinical Professor, PhDTaking people

About the trial

What the trial wants to find out

The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study will focus on people with type 2 diabetes living in specified vulnerable zip codes.

The group in the trial

  • Type 2 Diabetes

    The study will include adults with Type 2 Diabetes living in an urban setting characterized by poor health outcomes.

    Treatment: Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Leveraging the Exposome and Patient Sensor Data to Enhance Personalized Diabetes Care Across Diverse Communities
Plain-language title
Tracking how daily life and surroundings affect blood sugar in type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06989008, who can take part
Record updated
25 May 2025